Target intelligence / Profile preview

Type 1 fimbriae of uropathogenic Escherichia coli (Type 1 pili)

Target
Type 1 pili
Molecular classification
Adhesin, Lectin, Bacterial surface organelle, Chaperone-usher pathway pilus
01

Overview

Type 1 fimbriae are filamentous surface organelles found on uropathogenic Escherichia coli (UPEC) that play a critical role in the pathogenesis of urinary tract infections (UTIs). These structures are composed of a major subunit, FimA, and a distal adhesin, FimH, which specifically recognizes and binds to terminal mannose residues on uroplakin receptors of the bladder epithelium. This binding is essential for bacterial colonization, invasion of host cells, and the formation of intracellular bacterial communities that contribute to recurrent infections. Because Type 1 fimbriae are vital for the initial stages of infection, they are a primary target for anti-adhesive therapies, such as mannosides and FimH inhibitors, which aim to prevent bacterial attachment without exerting the selective pressure typical of traditional antibiotics. Research into these fimbriae also focuses on their role in biofilm formation and their potential as vaccine candidates to provide broad protection against UPEC-mediated diseases.

Other names
Type 1 piliFimH adhesinFim fimbriaeMannose-sensitive hemagglutininUPEC fimbriae
02

Mechanism of action

Competitive inhibition of the FimH lectin domain, preventing the binding of bacteria to mannosylated uroplakins on the bladder epithelium.

03

Biological functions

Bacterial adhesionHost cell colonizationBiofilm formationInvasion of host cellsIntercellular bacterial community (IBC) formation
04

Disease associations

Urinary tract infection (UTI)CystitisPyelonephritisUrosepsis
05

Safety considerations

Potential disruption of commensal gut microbiotaDevelopment of bacterial resistance through FimH mutationsLimited efficacy against non-mannose-dependent strains
06

Interacting drugs

D-Mannose

4 more in the full profile.

07

Biomarkers

FimH sequence variantsUrinary bacterial loadMannose-sensitive hemagglutination titer

Beyond the preview

Go deeper on Type 1 fimbriae of uropathogenic Escherichia coli (Type 1 pili).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Type 1 fimbriae of uropathogenic Escherichia coli (Type 1 pili).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call